Work

A Randomized Trial of Valacyclovir Versus Valganciclovir To Prevent CMV Reactivation in Patients with CLL Receiving Alemtuzumab.

Year: 2005

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Blood

DOI: 10.1182/blood.v106.11.2960.2960

Authors: Susan O’Brien, Farhad Ravandi-Kashani, William G. Wierda, Francis Giles, Deborah Thomas, Xuelin Huang, Todd D. Riehl, Jeffrey J. Tarrand, O’Neal Brandi, Hagop M. Kantarjian, Michael J. Keating

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Cytomegalovirus and herpesvirus research

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2523723746

FWCI: 1.091

Cites:

Cited by: 18

Related to: 10